Biomedical engineers have discovered a pharmaceutical target that,when activated,can reverse bone degradation caused by osteoporosis in mouse models of the dise
The debate over how one of the most popular osteoarthritis treatments should be federally regulated could change,thanks to a Cornell University study and a new